Erectile dysfunction and hypogonadism among men with HIV

Nancy F. Crum-Cianflone, Mary Bavaro, Braden Hale, Christopher Amling, April Truett, Carolyn Brandt, Brandie Pope, Kari Furtek, Sheila Medina, Mark R. Wallace

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1-1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4%; of those with ED, 32% did not have a rigid enough erection for penetration, and 46% were unable to sustain an erection for the completion of intercourse. In the rnultivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p <0.001) and depression (OR 2.64, p <0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25% of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.

Original languageEnglish (US)
Pages (from-to)9-19
Number of pages11
JournalAIDS Patient Care and STDs
Volume21
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Hypogonadism
Erectile Dysfunction
HIV
Odds Ratio
Testosterone
Phosphodiesterase 5 Inhibitors
CD4 Lymphocyte Count
Body Mass Index
Smoking
Depression
Therapeutics
Serum

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management
  • Nursing(all)

Cite this

Crum-Cianflone, N. F., Bavaro, M., Hale, B., Amling, C., Truett, A., Brandt, C., ... Wallace, M. R. (2007). Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care and STDs, 21(1), 9-19. https://doi.org/10.1089/apc.2006.0071

Erectile dysfunction and hypogonadism among men with HIV. / Crum-Cianflone, Nancy F.; Bavaro, Mary; Hale, Braden; Amling, Christopher; Truett, April; Brandt, Carolyn; Pope, Brandie; Furtek, Kari; Medina, Sheila; Wallace, Mark R.

In: AIDS Patient Care and STDs, Vol. 21, No. 1, 01.2007, p. 9-19.

Research output: Contribution to journalArticle

Crum-Cianflone, NF, Bavaro, M, Hale, B, Amling, C, Truett, A, Brandt, C, Pope, B, Furtek, K, Medina, S & Wallace, MR 2007, 'Erectile dysfunction and hypogonadism among men with HIV', AIDS Patient Care and STDs, vol. 21, no. 1, pp. 9-19. https://doi.org/10.1089/apc.2006.0071
Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care and STDs. 2007 Jan;21(1):9-19. https://doi.org/10.1089/apc.2006.0071
Crum-Cianflone, Nancy F. ; Bavaro, Mary ; Hale, Braden ; Amling, Christopher ; Truett, April ; Brandt, Carolyn ; Pope, Brandie ; Furtek, Kari ; Medina, Sheila ; Wallace, Mark R. / Erectile dysfunction and hypogonadism among men with HIV. In: AIDS Patient Care and STDs. 2007 ; Vol. 21, No. 1. pp. 9-19.
@article{2f4cef01a5e2428eb8ca1eaf28c90824,
title = "Erectile dysfunction and hypogonadism among men with HIV",
abstract = "Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1-1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4{\%}; of those with ED, 32{\%} did not have a rigid enough erection for penetration, and 46{\%} were unable to sustain an erection for the completion of intercourse. In the rnultivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p <0.001) and depression (OR 2.64, p <0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25{\%} of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.",
author = "Crum-Cianflone, {Nancy F.} and Mary Bavaro and Braden Hale and Christopher Amling and April Truett and Carolyn Brandt and Brandie Pope and Kari Furtek and Sheila Medina and Wallace, {Mark R.}",
year = "2007",
month = "1",
doi = "10.1089/apc.2006.0071",
language = "English (US)",
volume = "21",
pages = "9--19",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Erectile dysfunction and hypogonadism among men with HIV

AU - Crum-Cianflone, Nancy F.

AU - Bavaro, Mary

AU - Hale, Braden

AU - Amling, Christopher

AU - Truett, April

AU - Brandt, Carolyn

AU - Pope, Brandie

AU - Furtek, Kari

AU - Medina, Sheila

AU - Wallace, Mark R.

PY - 2007/1

Y1 - 2007/1

N2 - Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1-1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4%; of those with ED, 32% did not have a rigid enough erection for penetration, and 46% were unable to sustain an erection for the completion of intercourse. In the rnultivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p <0.001) and depression (OR 2.64, p <0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25% of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.

AB - Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1-1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4%; of those with ED, 32% did not have a rigid enough erection for penetration, and 46% were unable to sustain an erection for the completion of intercourse. In the rnultivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p <0.001) and depression (OR 2.64, p <0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25% of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.

UR - http://www.scopus.com/inward/record.url?scp=33846828729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846828729&partnerID=8YFLogxK

U2 - 10.1089/apc.2006.0071

DO - 10.1089/apc.2006.0071

M3 - Article

C2 - 17263654

AN - SCOPUS:33846828729

VL - 21

SP - 9

EP - 19

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 1

ER -